Loeb S, Li R, Sanchez Nolasco T, Byrne N, Cheng HH, Becker D, Leader AE, Giri VN.
“Barriers and facilitators of germline genetic evaluation for prostate cancer”
2021 May 31. PMID: 3405723.
Link: https://pubmed.ncbi.nlm.nih.gov/34057231/
Germline genetic testing is currently underutilized in prostate cancer management. In this qualitative study, we identified numerous barriers to genetic evaluation among healthcare providers, patients, hospital systems, and society.